#genengnews
Enhanced Efficacy for Next-Gen Antibody Therapies
Genengnews
Enhanced Efficacy for Next-Gen Antibody Therapies
www.genengnews.com
August 24, 2023 at 12:30 PM
🧬🦠 Cross-reactive #TCells that recognize both #Measles and #NipahVirus could help guide broader #vaccines and immune-based treatments.

#Virology #Immunology #Microbiology #PublicHealth #Microsky via genengnews .com
Cross-Reactive T Cells Could Point to Broad Vaccines or Treatments for Measles, Nipah Virus
Study showed that measles-fighting T cells could cross-react and also recognize Nipah virus.
www.genengnews.com
June 4, 2026 at 4:30 AM
Researchers Characterize Five Types of Colon Nerve Cells That Signal to the Brain
Genengnews
Researchers Characterize Five Types of Colon Nerve Cells That Signal to the Brain
www.genengnews.com
August 5, 2023 at 7:01 AM
CZI to Build Massive GPU Cluster for Decoding Biology with AI
Genengnews
CZI to Build Massive GPU Cluster for Decoding Biology with AI
www.genengnews.com
September 22, 2023 at 11:04 AM
🫁🦠 Different #Pneumococcus subtypes respond differently to air #pollution, helping explain how #environmental exposure can influence the risk of #pneumococcal #disease.

#Microbes #Bacteria #AirPollution #Streptococcus #Infections #Microsky via genengnews .com

www.genengnews.com/topics/infec...
Pneumococcal Subtypes Influence the Impact of Air Pollution on Disease Risk
Pneumococcal bacterial subtypes influence how air pollution affects invasive disease risk.
www.genengnews.com
September 16, 2026 at 10:30 PM
Spatial Biology and AI Combined by Noetik to Develop Immuno-Oncology Drugs
Genengnews
Spatial Biology and AI Combined by Noetik to Develop Immuno-Oncology Drugs
www.genengnews.com
September 14, 2023 at 9:18 AM
Did you see this piece in GenEngNews about the 2026 HCA General Meeting, celebrating a decade of HCA discovery and the ambitious road to the next phase of HCA?
Read the interview with @hoheyn.bsky.social about our achievements and plans for HCA 2.0 at buff.ly/pfwhKYW
🖥️ 🧬 #Genomics #HumanCellAtlas
Human Cell Atlas at 10: A Decade of Discovery and the Road to HCA 2.0
Marking its 10th anniversary, the Human Cell Atlas reflects on a decade of breakthroughs while charting an ambitious course for the next decade.
www.genengnews.com
August 28, 2026 at 5:01 PM
🍄🦠 #Candida Auris can persist deep inside #hair follicles and manipulate immune signaling, helping explain how this #drug-resistant #fungus colonizes human #skin.

#Fungi #AMR #Microbiology #Immunology #Microsky via genengnews .com

www.genengnews.com/topics/infec...
Candida auris Persists in Hair Follicles, Hijacks Immune Signaling
Drug-resistant Candida auris was found to persist in hair follicles by exposing chitin.
www.genengnews.com
August 12, 2026 at 4:30 PM
Emerging Infectious Diseases Prompt a Layered Response
Genengnews
Emerging Infectious Diseases Prompt a Layered Response
www.genengnews.com
August 16, 2023 at 8:15 AM
Utility of Antisense Oligonucleotides (ASOs) in Next-Generation Biotherapeutics
Genengnews
Utility of Antisense Oligonucleotides (ASOs) in Next-Generation Biotherapeutics
www.genengnews.com
September 8, 2023 at 3:10 AM
Alzheimer's Vaccine Candidate ALZ-101 Begins Phase II Clinical Study | GenEngNews www.genengnews.com/topics/trans...
Alzheimer's Vaccine Candidate ALZ-101 Begins Phase II Clinical Study
FDA has approved Alzinova's IND application for a Phase II clinical study with the vaccine candidate ALZ-101 in Alzheimer’s disease.
www.genengnews.com
September 10, 2025 at 3:13 PM
A team of researchers from the Harvard Medical School, and McLean Hospital have identified at last how the mutation causes symptom development later in life, opening doors to therapeutic approaches for delaying or preventing development of the disease. | GENengNews
Groundbreaking Huntington Study Reveals Somatic DNA-Repeat Expansion
How the mutation in the huntingtin gene functions to cause the disease has eluded researchers—until now.
buff.ly
January 28, 2025 at 9:50 PM
Utility of Antisense Oligonucleotides (ASOs) in Next-Generation Biotherapeutics
Genengnews
Utility of Antisense Oligonucleotides (ASOs) in Next-Generation Biotherapeutics
www.genengnews.com
September 8, 2023 at 6:17 AM
Shuttle Launch: Cellares’ Smart Factories Aim to Meet Cell Therapy Demand at Global Scale
Genengnews
Shuttle Launch: Cellares’ Smart Factories Aim to Meet Cell Therapy Demand at Global Scale
www.genengnews.com
September 14, 2023 at 6:55 AM